Sirtuin 1, Visfatin and IL-27 Serum Levels of Type 1 Diabetic Females in Relation to Cardiovascular Parameters and Autoimmune Thyroid Disease
Magdalena Łukawska-Tatarczuk,
Edward Franek,
Leszek Czupryniak,
Ilona Joniec-Maciejak,
Agnieszka Pawlak,
Ewa Wojnar,
Jakub Zieliński,
Dagmara Mirowska-Guzel,
Beata Mrozikiewicz-Rakowska
Affiliations
Magdalena Łukawska-Tatarczuk
Clinical Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital of the Ministry of Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland
Edward Franek
Clinical Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital of the Ministry of Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland
Leszek Czupryniak
Department of Diabetology and Internal Diseases, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland
Ilona Joniec-Maciejak
Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland
Agnieszka Pawlak
Mossakowski Medical Research Centre, Polish Academy of Sciences, Adolfa Pawińskiego 5, 02-106 Warsaw, Poland
Ewa Wojnar
Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland
Jakub Zieliński
Interdisciplinary Centre for Mathematical and Computational Modeling, University of Warsaw, Adolfa Pawińskiego 5A, 02-106 Warsaw, Poland
Dagmara Mirowska-Guzel
Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland
Beata Mrozikiewicz-Rakowska
Department of Diabetology and Internal Diseases, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland
The loss of cardioprotection observed in premenopausal, diabetic women may result from the interplay between epigenetic, metabolic, and immunological factors. The aim of this study was to evaluate the concentration of sirtuin 1, visfatin, and IL-27 in relation to cardiovascular parameters and Hashimoto’s disease (HD) in young, asymptomatic women with type 1 diabetes mellitus (T1DM). Thyroid ultrasound, carotid intima-media thickness (cIMT) measurement, electrocardiography, and echocardiography were performed in 50 euthyroid females with T1DM (28 with HD and 22 without concomitant diseases) and 30 controls. The concentrations of serum sirtuin 1, visfatin and IL-27 were assessed using ELISA. The T1DM and HD group had higher cIMT (p = 0.018) and lower left ventricular global longitudinal strain (p = 0.025) compared to females with T1DM exclusively. In women with a double diagnosis, the sirtuin 1 and IL-27 concentrations were non-significantly higher than in other groups and significantly positively correlated with each other (r = 0.445, p = 0.018) and thyroid volume (r = 0.511, p = 0.005; r = 0.482, p = 0.009, respectively) and negatively correlated with relative wall thickness (r = –0.451, p = 0.016; r = –0.387, p = 0.041, respectively). These relationships were not observed in the control group nor for the visfatin concentration. These results suggest that sirtuin 1 and IL-27 contribute to the pathogenesis of early cardiac dysfunction in women with T1DM and HD.
